Jeffrey E. Topal
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Antimicrobial Resistance in Staphylococcus 11
- Antifungal resistance and susceptibility 9
- COVID-19 Clinical Research Studies 5
- Clostridium difficile and Clostridium perfringens research 5
- Epidemiology 20
- Co-authors
- Richard A. Martinello (3 shared papers)Laura Jones (1 shared paper)Dayna S. McManus (42 shared papers)Guadalupe García–Tsao (1 shared paper)Puneeta Tandon (1 shared paper)Thomas J. Balcezak (3 shared papers)Sunish Shah (13 shared papers)Peter Herbert (2 shared papers)
- Journals
- Open Forum Infectious Diseases (9 papers)Infection Control and Hospital Epidemiology (5 papers)Journal of Antimicrobial Chemotherapy (5 papers)Journal of Clinical Microbiology (3 papers)Journal of the National Comprehensive Cancer Network (3 papers)
- Partner nations
- United StatesItalyIndia
In The Last Decade
Jeffrey E. Topal
74 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 114
- Applied Microbiology and Biotechnology 86
- Infectious Diseases 637
- Parasitology 148
- Epidemiology 660
- Hepatology 129
Countries citing papers authored by Jeffrey E. Topal
This map shows the geographic impact of Jeffrey E. Topal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey E. Topal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey E. Topal more than expected).
Fields of papers citing papers by Jeffrey E. Topal
This network shows the impact of papers produced by Jeffrey E. Topal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey E. Topal. The network helps show where Jeffrey E. Topal may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey E. Topal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 325 | |
| 2 | 2003 | 200 | |
| 3 | 2020 | 172 | |
| 4 | 2012 | 137 | |
| 5 | 2005 | 114 | |
| 6 | 2010 | 107 | |
| 7 | 2005 | 85 | |
| 8 | 2020 | 70 | |
| 9 | 2020 | 51 | |
| 10 | 2001 | 50 | |
| 11 | 2009 | 38 | |
| 12 | 2004 | 35 | |
| 13 | 2024 | 35 | |
| 14 | 2020 | 33 | |
| 15 | 2001 | 28 | |
| 16 | 2015 | 26 | |
| 17 | 2012 | 20 | |
| 18 | 2013 | 20 | |
| 19 | 2014 | 20 | |
| 20 | 2003 | 19 |
About Jeffrey E. Topal
Jeffrey E. Topal is a scholar working on Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology, Pharmacology and Clinical Biochemistry, having authored 80 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (11 papers), Antifungal resistance and susceptibility (9 papers), Neutropenia and Cancer Infections (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Use and Resistance (6 papers), COVID-19 Clinical Research Studies (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (86 citations), Infectious Diseases (637 citations), Parasitology (148 citations), Epidemiology (660 citations) and Hepatology (129 citations). Jeffrey E. Topal has collaborated with scholars based in United States, Italy and India. Frequent co-authors include Richard A. Martinello, Laura Jones, Dayna S. McManus, Guadalupe García–Tsao, Puneeta Tandon, Thomas J. Balcezak, Sunish Shah, Peter Herbert, David R. Peaper and Matteo Bassetti. Their work appears in journals such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.